| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/29/1993 | US5223421 Identification of methionine Nα-acetyltransferase |
| 06/29/1993 | US5223419 Alteration of gene expression in plants |
| 06/29/1993 | US5223418 Using casamino acid |
| 06/29/1993 | US5223409 Directed evolution of novel binding proteins |
| 06/29/1993 | US5223408 Method for making variant secreted proteins with altered properties |
| 06/29/1993 | US5223407 Culturing genetically transformed E. coli strains |
| 06/29/1993 | US5223394 Recombinant dna molecule comprising lymphocyte function-associated antigen 3 phosphatidylinositol linkage signal sequence |
| 06/29/1993 | US5223392 Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore |
| 06/29/1993 | US5223256 Thrombolytically active non-glycosylated protein |
| 06/29/1993 | US5223254 Polypeptide |
| 06/29/1993 | CA2121134A1 Novel thrombin-inhibitory protein from ticks |
| 06/29/1993 | CA1319631C Method for the production of proteins by means of inducible expression systems in genetically modified eukaryotic host-cells multiplicated in-vivo |
| 06/29/1993 | CA1319630C Method of regulating expression of a foreign gene by controlling the sugar concentration in a medium and a process of producing a foreign gene product thereby |
| 06/29/1993 | CA1319629C Fusion proteins |
| 06/29/1993 | CA1319628C Fusion proteins |
| 06/28/1993 | CA2086162A1 Oligonucleotides, oligopeptides and determination system of hcv antibody subtype |
| 06/25/1993 | CA2126748A1 Manipulating nucleic acid sequences |
| 06/24/1993 | WO1993012257A1 Enzymatic inverse polymerase chain reaction library mutagenesis |
| 06/24/1993 | WO1993012251A1 Senescent cell derived inhibitors of dna synthesis |
| 06/24/1993 | WO1993012247A1 In vitro antibody production |
| 06/24/1993 | WO1993012246A1 Expression-secretion vectors for the production of biologically active fv fragments |
| 06/24/1993 | WO1993012245A1 Method for exponential amplification of nucleic acid by a single unpaired primer |
| 06/24/1993 | WO1993012244A1 Construction of geometrical objects from polynucleotides |
| 06/24/1993 | WO1993012240A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | WO1993012239A1 Alteration of plant and plant cell growth characteristics |
| 06/24/1993 | WO1993012238A1 t-PA SUBSTITUTION VARIANTS WITH IMPROVED FIBRIN-SPECIFICITY |
| 06/24/1993 | WO1993012237A1 Process for producing/secreting a protein by a transformed mould using expression/secretion regulating regions derived from an aspergillus endoxylanase ii gene |
| 06/24/1993 | WO1993012236A1 Constitutive expression of p450soy and ferredoxin-soy in streptomyces, and biotransformation of chemicals by recombinant organisms |
| 06/24/1993 | WO1993012235A1 Materials and methods for biosynthesis of serine and serine-related products |
| 06/24/1993 | WO1993012234A1 Antiviral reagents based on rna-binding proteins |
| 06/24/1993 | WO1993012233A1 Mammalian cell-based dna libraries |
| 06/24/1993 | WO1993012232A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | WO1993012231A1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72 |
| 06/24/1993 | WO1993012230A1 Triple-helix formation at (punpyn).(punpyn) tracts |
| 06/24/1993 | WO1993012229A1 Method for preparing double stranded rna, and use thereof |
| 06/24/1993 | WO1993012228A1 Method for generating structural and functional diversity in a peptide sequence |
| 06/24/1993 | WO1993012227A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 06/24/1993 | WO1993012225A1 Novel tissue plasminogen activator variants |
| 06/24/1993 | WO1993012143A1 Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 06/24/1993 | WO1993012134A1 Diagnosis of hereditary retinal degenerative diseases |
| 06/24/1993 | WO1993012133A1 Transcriptional cofactor regulation of expression |
| 06/24/1993 | WO1993012129A1 Peptide nucleic acids and their effect on genetic material |
| 06/24/1993 | WO1993012127A1 PLATELET GPIIIa P1?A1 AND P1A2¿ EPITOPES, THEIR PREPARATION AND USE |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | WO1993011792A1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
| 06/24/1993 | WO1993011257A3 Process for screening substances capable of modulating a receptor-dependent cellular signal transmission path |
| 06/24/1993 | DE4142552A1 Monoklonale antikoerper gegen die typ i phospholipase a(pfeil abwaerts)2(pfeil abwaerts) als entzuendungshemmendes therapeutikum Monoclonal antibodies against type I phospholipase A (down arrow) 2 (down arrow) as therapeutic entzuendungshemmendes |
| 06/24/1993 | DE4142452A1 Mittel zur stimulierung der teilungsaktivitaet tierischer zellen Means for stimulation of teilungsaktivitaet animal cells |
| 06/24/1993 | CA2126101A1 Gene therapy for cystic fibrosis transmembrane conductance regulator activity (cftr) |
| 06/24/1993 | CA2125966A1 Peptide nucleic acids and their effect on genetic material |
| 06/24/1993 | CA2125947A1 Constitutive expression of p450soy and ferredoxin-soy in streptomyces, and biotransformation of chemicals by recombinant organisms |
| 06/24/1993 | CA2125396A1 Reactive neutralizing human anti-gp 120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | CA2125192A1 A process for generating a structural and functional diversity in a peptide sequence |
| 06/24/1993 | CA2124786A1 In vitro antibody production |
| 06/24/1993 | CA2085828A1 Serpulina hyodysenteriae vaccine |
| 06/23/1993 | EP0548056A1 A process for cloning methylated DNA in a bacterial host incapable of host restriction |
| 06/23/1993 | EP0548012A1 Endoplastic reticulum-located recombinant dibasic endoprotease and uses thereof |
| 06/23/1993 | EP0547920A2 Recombinant thermostable DNA polymerase from archaebacteria |
| 06/23/1993 | EP0547876A1 Gene encoding enzyme having flavin reducing activity and nitroreductase activity |
| 06/23/1993 | EP0547873A2 A novel translational activating sequence |
| 06/23/1993 | EP0547789A1 Process for lysing mycobacteria |
| 06/23/1993 | EP0547631A2 Antibody expression vector and antibodies produced thereby |
| 06/23/1993 | EP0547446A2 Vaccines based on modified bovine herpesvirus type I |
| 06/23/1993 | EP0547403A1 Regulated expression of tetracycline resistance determinant (TETK) in escheria coli |
| 06/23/1993 | EP0547359A1 Purified thermostable dna polymerase obtainable from pyrococcus species |
| 06/23/1993 | EP0547201A1 Phagemide for screening antibodies |
| 06/23/1993 | EP0547200A1 Recombinant antibodies at the surface of e. coli |
| 06/23/1993 | EP0547180A1 Recombinant agents affecting thrombosis |
| 06/23/1993 | EP0547171A1 Production of human lysozyme in methylotrophic yeast cells and efficient secretion therefrom |
| 06/23/1993 | EP0547163A1 Protein polyligands joined to a stable protein core |
| 06/23/1993 | EP0547149A1 Inhibition of herpesviridae infection by antisense oligonucleotides |
| 06/23/1993 | EP0547076A1 Cd58-specific monoclonal antibodies and their use |
| 06/23/1993 | EP0547074A1 Human mitochondrial nad(p)?+ -dependent malate enzyme |
| 06/23/1993 | EP0547065A1 Melanin production by transformed microorganisms |
| 06/23/1993 | EP0547059A1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies. |
| 06/23/1993 | EP0263172B1 Protein analogues of tissue plasminogen activator |
| 06/23/1993 | EP0249635B1 Word recognition in a speech recognition system using data reduced word templates |
| 06/23/1993 | EP0236330B1 Dna sequence encoding a hirudin-like protein and process for preparing such protein |
| 06/23/1993 | CN1073484A Methods and reagents for HLA class I DNA typing |
| 06/23/1993 | CN1073476A Dye transfer inhibiting compositions |
| 06/22/1993 | US5221789 Interferon-gamma receptor fragment and its production |
| 06/22/1993 | US5221740 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 06/22/1993 | US5221738 cDNA and genomic DNA encoding the amino acid sequence of human α2 -plasmin inhibition |
| 06/22/1993 | US5221737 Gene and gene structure coding for an aminotransferase, and microorganisms which express this gene |
| 06/22/1993 | US5221736 Sequential peptide and oligonucleotide syntheses using immunoaffinity techniques |
| 06/22/1993 | US5221624 DNA encoding (Lys46, Asp97, Asp113) and (Lys46, Asp.sup.137) thaumatin I polypeptides |
| 06/22/1993 | US5221623 Use of bacterial luciferase structural genes for cloning and monitoring gene expression in microorganisms and for tagging and identification of genetically engineered organisms |
| 06/22/1993 | US5221620 Cloning and expression of transforming growth factor β2 |
| 06/22/1993 | US5221619 Method and means for microbial polypeptide expression |
| 06/22/1993 | US5221618 Genetic detoxification of pertussis toxin |
| 06/22/1993 | US5221608 Adding a polymerase and an isopsoralen compound to a mixture of nucleic acid and amplification reagents, and exposing to ultraviolet radiation to form isopsoralen monoadduct which inhibits polymerase |
| 06/22/1993 | CA1319337C Newcastle disease virus gene clones |
| 06/22/1993 | CA1319336C Means and method for enhancing nucleic acid hybridization |
| 06/21/1993 | CA2085803A1 Purified para-nitrobenzyl esterase from bacillus |
| 06/20/1993 | CA2085806A1 Recombinant dna compounds and expression vectors encoding para-nitrobenzyl esterase activity from bacillus |
| 06/20/1993 | CA2058116A1 Production and secretion of proteins and polypeptides by yeast |
| 06/19/1993 | CA2085447A1 A novel translational activating sequence |
| 06/19/1993 | CA2059611A1 L-phenylalanyl-trna synthetase mutants, a process for the preparation thereof and the use thereof for the in vivo incorporation of non-proteinogenous amino acids into peptides or proteins |
| 06/18/1993 | EP0597845A4 GROWTH FACTOR WHICH INHIBITS THE GROWTH OF CELLS OVEREXPRESSING THE HUMAN ONCOGENE erbB-2. |
| 06/18/1993 | EP0559834A4 Immunoassay and monoclonal antibodies useful for detecting truncated nerve growth factor receptor. |